Form 4: Encompass Health CEO's Stock Withholding for Taxes
Insider Transaction Report
Encompass Health Corp's President & CEO, Mark J. Tarr, reported the withholding of shares to cover tax obligations related to restricted stock vesting.
Summary
- Mark J. Tarr, President & CEO and Director of Encompass Health Corp (EHC), reported transactions involving the company's common stock.
- On February 19, 2026, 43,378 shares of Encompass Health Common Stock were disposed of at a price of $107.15 per share.
- On February 20, 2026, an additional 1,797 shares of Encompass Health Common Stock were disposed of at a price of $106.55 per share.
- These dispositions were not discretionary sales but rather shares withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of related restricted stock.
- Following these transactions, Mark J. Tarr beneficially owns 445,637 shares of Encompass Health Common Stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral. The transactions represent a routine, non-discretionary event for tax purposes related to equity compensation, rather than a discretionary sale or purchase indicating a change in insider sentiment.
Management Comments
- Shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of related restricted stock.
Industry Context
StockSavvy.ai notes that the withholding of shares to cover tax obligations upon the vesting of restricted stock is a common and routine practice for executives receiving equity compensation across various industries. This type of transaction is typically non-discretionary and does not reflect a change in management's sentiment towards the company's future prospects.
Stakeholder Impact
- Shareholders: The transactions result in a minor reduction in the direct beneficial ownership of the CEO, but this is a standard administrative process for equity compensation and not indicative of a change in company fundamentals or management confidence.
Key Dates
| Date | Description |
|---|---|
| 02/19/2026 | Date of disposition of 43,378 shares of Encompass Health Common Stock for tax withholding. |
| 02/20/2026 | Date of disposition of 1,797 shares of Encompass Health Common Stock for tax withholding. |
| 02/23/2026 | Date the Form 4 was signed by Patrick Darby, attorney-in-fact for Mark J. Tarr. |
Recommendation
holdThe filing details routine tax-related stock withholdings by the CEO, which are non-discretionary and do not signal any change in the company's operational performance or future outlook. Therefore, this specific filing does not provide a basis for altering an investment recommendation.
Keywords
Encompass Health, EHC, Form 4, Insider Transaction, Stock Withholding, Mark J. Tarr, Restricted Stock Vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.